Status:
COMPLETED
Adenoid Hypertrophy, Respiratory Complications and Correlation With Infant Feeding Position
Lead Sponsor:
Hadassah Medical Organization
Collaborating Sponsors:
Clalit Health Services
Conditions:
Adenoid Hypertrophy
Eligibility:
All Genders
1-5 years
Brief Summary
500 children aged 0-5 years followed since birth by Principal Investigator (PI)since January1, 2003 till December 31, 2018 and diagnosed with adenoid hypertrophy (AH) (study group) and 500 children ag...
Detailed Description
The 2 groups are children aged 0-5 years and treated by PI and followed since birth during years 2003-2018. Study group consists of children diagnosed at least 2 times as AH and control group as simil...
Eligibility Criteria
Inclusion
- Study group: Young children with diagnosis of adenoid hypertrophy followed by PI Control group: young children with diagnosis of UTI, GE, vomiting or diarrhea followed by PI
Exclusion
- Children with cystic fibrosis, primary dyskinesia, immune deficiency, congenital anatomical malformations of nasal or airway passages.
- Children older than 6 months of age when starting to be followed by PI.
Key Trial Info
Start Date :
January 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 6 2020
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04431128
Start Date
January 1 2003
End Date
June 6 2020
Last Update
June 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hadassah Medical Organization, Jerusalem, Israel
Jerusalem, Israel, P.P.Box 12000